After bioprosthetic aortic valve replacement, patients who took the oral drug warfarin had better outcomes including lower mortality rates and fewer blood clots, according to new research from ...

Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective ...

Read more about how transcatheter aortic valve implantation results in a higher risk of mortality and stroke compared with surgical replacement.

Study validates a new risk model that allows for more accurate risk estimates, encourages shared decision-making, and helps ...

Transcatheter aortic valve replacement (TAVR) demonstrated better short-term outcomes, while surgical aortic valve replacement (SAVR) had better long-term outcomes. A recent study found that when it ...

Washington, D.C. – MAY 1, 2025 – Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that single antiplatelet therapy (SAPT) after ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...

Biological age acceleration, independently tied to higher all-cause mortality in patients with moderate-to-severe aortic ...

LOS ANGELES -- Survival outcomes favored mechanical valves for isolated surgical aortic valve replacement (SAVR) for people until age 60, after which a tissue valve may start to have an advantage, ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, today announced results from a new study demonstrating that its AI-enabled ECG technology, AK-AVS™, can detect ...